Fosinopril Sodium (Dispensing Solutions, Inc.)
Welcome to the PulseAid listing for the Fosinopril Sodium drug offered from Dispensing Solutions, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dispensing Solutions, Inc. |
NON-PROPRIETARY NAME: | Fosinopril Sodium |
SUBSTANCE NAME: | FOSINOPRIL SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-04-23 |
END MARKETING DATE: | 0000-00-00 |
Fosinopril Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Fosinopril Sodium from Dispensing Solutions, Inc. |
LABELER NAME: | Dispensing Solutions, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2004-04-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68258-6106_649f5bc7-7ee3-42bd-84b0-8a0650a9582c |
PRODUCT NDC: | 68258-6106 |
APPLICATION NUMBER: | ANDA076483 |
Other FOSINOPRIL SODIUM Pharmaceutical Manufacturers / Labelers: